Influenza Vaccine(Split Virion), Inactivated (Lanzhou Institute Of Biological Products)

流感病毒裂解疫苗（兰州生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza Vaccine(Split Virion), Inactivated (Lanzhou Institute Of Biological Products)
Drug Alias Name英扶宁
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2005/02/06
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLanzhou Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLanzhou Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02
Related LinksN/A